INTERPLAY OF DRUG TRANSPORTERS AND ENZYMES ON HEPATIC DRUG PROCESSING - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 739

12. Tirona, RG, Tan E, Meier G, Pang KS. 1999. Uptake and glutathione conjugation kinetics
of ethacrynic acid in rat liver: in vitro and perfusion studies. J Pharmacol Exp Ther
291:1210-1219.
13. Pang KS, Terrell JA. 1981. Retrograde perfusion to probe the heterogeneous distribution
of hepatic drug metabolizing enzymes in rats. J Pharmacol Exp Ther 216:339-346.
14. Abu-Zahra TN, Pang KS. 2000. Effect of zonal transport and metabolism on hepatic
removal: enalapril hydrolysis in zonal, isolated rat hepatocytes in vitro and correlation
with perfusion data. Drug Metab Dispos 28:807-813.
15. Hjelle JJ, Hazelton GA, Klaassen CD. 1985. Acetaminophen decreases adenosine 3 -
phosphate 5 -phosphosulfate and uridine diphosphoglucuronic acid in rat liver. Drug
Metab Dispos 13:35-41.
16. Dills RL, Howell SR, Klaassen CD. 1987. Hepatic UDP-glucose and UDP-glucuornic
acid synthesis rates in rats during a reduced energy state. Drug Metab Dispos 15:281-288.
17. Wagner JG, DiSanto AR, Gillespie WR, Albert KS. 1981. Reversible metabolism and
pharmacokinetics: application to prednisone-prednisolone. Res Commun Chem Pathol
Pharmacol 32:387-405.
18. Ebling WF, Szefler SJ, Jusko WJ. 1986. Methylprednisolone disposition in rabbits: anal-
ysis, prodrug conversion, reversible metabolism, and comparison with man. Drug Metab
Dispos 13:296-304.
19. Cheng HY, Jusko WJ. 1990. Mean interconversion times and distribution rate parameters
for drugs undergoing reversible metabolism. Pharm Res 7:1003-1110.
20. Ratna S, Chiba M, Bandyopadhyay L, Pang KS. 1993. Futile cycling between 4-
methylumbelliferone and its conjugates in perfused rat liver. Hepatology 17:838-853.
21. Tan E, Pang KS. 2001. Sulfation is rate limiting in the futile cycling between estrone and
estrone sulfate in enriched periportal and perivenous rat hepatocytes. Drug Metab Dispos
29:335-346.
22. Tan E, Lu T, Pang KS. 2001. Futile cycling of estrone sulfate and estrone in the recircu-
lating, perfused rat liver. J Pharmacol Exp Ther 297:423-436.
23. Pang KS, Sherman IA, Schwab AJ, Geng W, Barker F III, Dlugosz JA, Cuerrier G,
Goresky CA. 1994. Role of the hepatic artery in the metabolism of phenacetin and ac-
etaminophen: an intravital microscopic and multiple indicator dilution study in perfused
rat liver. Hepatology 20:672-683.
24. Sherman IA, Barker F III, Dugloz J, Sadeghi FM, Pang KS. 1996. Dynamics of arterial
and portal flow interactions in perfused rat liver: an intravital microscopic study. Am J
Physiol 271:G201-G210.
25. Takasaki S, Hano H. 2001. Three-dimensional observations of the human hepatic artery
(arterial system in the liver). J Hepatol 34:455-466.
26. Foley DP, Ricciardi R, Traylor AN, McLaughlin TJ, Donohue SE, Wheeler SM, Meyers
WC, Quarfordt SH. 2003. Effect of hepatic artery flow on bile secretory function after
cold ischemia. Am J Transplant 3:148-155.
27. Pang KS, Rowland M. 1977. Hepatic clearance of drugs: II. Experimental evidence for
acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in
the perfused rat liver in situ preparation. J Pharmacokinet Biopharm 5:655-680.
28. Rowland M, Benet LZ, Graham GG. 1973. Clearance concepts in pharmacokinetics. J
Pharmacokinet Biopharm 1:123-136.